Results 211 to 220 of about 3,591,939 (354)

Final system report

D8.9 will on the one side contain: (i) the assessment of the functionality of the final system, compared with the targeted functionality specified for MS5; (ii) the summary of the evaluation of the performance of the individual techniques in accordance with the corresponding performance indicators; (iii) assessment of the overall user satisfaction and ...
openaire   +1 more source

Development of CAD system for frame structure as packing cage. (1st Report: Stress analysis and optimum design of frame structure).

, 1988
Yukio TADA, Ryuichi MATSUMOTO, Kenji YAMAMOTO   +2 more
openalex   +2 more sources

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Pharmacovigilance study on neurological adverse reactions of proteasome inhibitors in the FDA adverse event reporting system. [PDF]

Front Pharmacol
Li S, Ling T, Liu Y, Li J.
europepmc   +1 more source

Impurities and interface states in the silicon dioxide/silicon system Final report

, 1968
A. B. Kuper
openalex   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for bimekizumab. [PDF]

Front Pharmacol
Lin Z, Yu X, Yang M, Xu J, Zhong J.
europepmc   +1 more source

Monitroing report system

It will include information about the elements and variables which will be monitored, the used monitoring devices, the system to process the obtained information.
openaire   +1 more source

Incident Reporting Systems

, 2007
Systematic collection of safety incident / accident data has been common in many industries for decades. An equivalent effort has not been made in the area of information security, exclusive perhaps of highly specialized organizations with such needs.
openaire   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

Molecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source